Authors:
Farin, FM
Janssen, P
Quigley, S
Abbott, D
Hassett, C
Smith-Weller, T
Franklin, GM
Swanson, PD
Longstreth, WT
Omiecinski, CJ
Checkoway, H
Citation: Fm. Farin et al., Genetic polymorphisms of microsomal and soluble epoxide hydrolase and the risk of Parkinson's disease, PHARMACOGEN, 11(8), 2001, pp. 703-708
Authors:
Sidhu, JS
Liu, F
Boyle, SM
Omiecinski, CJ
Citation: Js. Sidhu et al., PI3K inhibitors reverse the suppressive actions of insulin on CYP2E1 expression by activating stress-response pathways in primary rat hepatocytes, MOLEC PHARM, 59(5), 2001, pp. 1138-1146
Citation: Bc. Krovat et al., Fingerprinting of cytochrome P450 and microsomal epoxide hydrolase gene expression in human blood cells, TOXICOL SCI, 55(2), 2000, pp. 352-360
Citation: Nb. Beck et al., Baculovirus vectors repress phenobarbital-mediated gene induction and stimulate cytokine expression in primary cultures of rat hepatocytes, GENE THER, 7(15), 2000, pp. 1274-1283
Authors:
Jinneman, KC
Weagant, SD
Johnson, JM
Abbott, SL
Hill, WE
Tenge, BJ
Dang, NL
Ramsden, R
Omiecinski, CJ
Citation: Kc. Jinneman et al., A large insertion in the Shiga-like toxin 2 gene (stx(2)) of an Escherichia coli O157 : H7 clinical isolate, INT J F MIC, 57(1-2), 2000, pp. 115-124
Authors:
Yamada, H
Matsunaga, H
Tsuji, K
Matsumoto, S
Yamamoto, M
Ishii, Y
Omiecinski, CJ
Oguri, K
Citation: H. Yamada et al., Sequence analyses of CYP2B genes and catalytic profiles for p450s in Qdj: Sprague-Dawley rats that lack response to the phenobarbital-mediated induction of CYP2B2, J PHARM EXP, 295(3), 2000, pp. 986-993
Authors:
Schilter, B
Andersen, MR
Acharya, C
Omiecinski, CJ
Citation: B. Schilter et al., Activation of cytochrome P450 gene expression in the rat brain by phenobarbital-like inducers, J PHARM EXP, 294(3), 2000, pp. 916-922
Authors:
Sandberg, M
Hassett, C
Adman, ET
Meijer, J
Omiecinski, CJ
Citation: M. Sandberg et al., Identification and functional characterization of human soluble epoxide hydrolase genetic polymorphisms, J BIOL CHEM, 275(37), 2000, pp. 28873-28881
Authors:
Hulla, JE
Miller, MS
Taylor, JA
Hein, DW
Furlong, CE
Omiecinski, CJ
Kunkel, TA
Citation: Je. Hulla et al., Symposium overview: The role of genetic polymorphism and repair deficiencies in environmental disease (vol 47, pg 135, 1999), TOXICOL SCI, 51(2), 1999, pp. 317-317
Authors:
Hulla, JE
Miller, MS
Taylor, JA
Hein, DW
Furlong, CE
Omiecinski, CJ
Kunkel, TA
Citation: Je. Hulla et al., Symposium overview: The role of genetic polymorphism and repair deficiencies in environmental disease, TOXICOL SCI, 47(2), 1999, pp. 135-143
Authors:
Ramsden, R
Beck, NB
Sommer, KM
Omiecinski, CJ
Citation: R. Ramsden et al., Phenobarbital responsiveness conferred by the 5 '-flanking region of the rat CYP2B2 gene in transgenic mice, GENE, 228(1-2), 1999, pp. 169-179
Authors:
Weagant, SD
Jagow, JA
Jinneman, KC
Omiecinski, CJ
Kaysner, CA
Hill, WE
Citation: Sd. Weagant et al., Development of digoxigenin-labeled PCR amplicon probes for use in the detection and identification of enteropathogenic Yersinia and Shiga toxin-producing Escherichia coli from foods, J FOOD PROT, 62(5), 1999, pp. 438-443
Citation: Nb. Beck et Cj. Omiecinski, Lack of modulation by phenobarbital of cyclic AMP levels or protein kinasea activity in rat primary hepatocytes, BIOCH PHARM, 58(7), 1999, pp. 1109-1114
Authors:
Hartsfield, JK
Sutcliffe, MJ
Everett, ET
Hassett, C
Omiecinski, CJ
Saari, JA
Citation: Jk. Hartsfield et al., Assignment of microsomal epoxide hydrolase (EPHX1) to human chromosome 1q42.1 by in situ hybridization, CYTOG C GEN, 83(1-2), 1998, pp. 44-45